CVS Health Corporation (CVS) belonging to the Retail-Wholesale sector has declined -0.85% and closed its last trading session at $78.88.
The company reported its EPS on 02/09/2017. Currently, the stock has a 1 Year Price Target of $86.52.
The consensus recommendation, according to Zacks Investment research, is 1.83. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 1.75 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1.61 and 1.45 respectively.
CVS Health Corporation on 02/09/2017 reported its EPS as $1.71 with the analysts projecting the EPS of the stock as $1.67. The company beat the analyst EPS Estimate with the difference of $0.04. This shows a surprise factor of 2.4%.
Many analysts have provided their estimated foresights on CVS Health Corporation Earnings, with 21 analysts believing the company would generate an Average Estimate of $1.1.
Whereas they predicted High and Low Earnings Estimate as $1.13 and $1.09 respectively. While in the same Quarter Previous year, the Actual EPS was $1.18.
Analysts are also projecting an Average Revenue Estimate for CVS Health Corporation as $44.23 Billion in the Current Quarter. This estimate is provided by 18 analysts.
The High Revenue estimate is predicted as 45.4 Billion, while the Low Revenue Estimate prediction stands at 43.93 Billion. The company’s last year sales total was 43.22 Billion.
For the Current Quarter, the growth estimate for CVS Health Corporation is -6.8%, while for the Next Quarter the stock growth estimate is 0%.
In the past 5 years, the stock showed growth of 14.55% per annum. While for the next 5 years, the growth estimate is 10.46%.
The Company got Downgrade by Atlantic Equities on 6-Feb-17 from Overweight to Neutral.
Insider Trades for CVS Health Corporation show that the latest trade was made on 12 Mar 2017 where Sussman Andrew J, the Officer completed a transaction type “Sell” in which 6655 shares were traded at a price of $80.4.
6 Insider Sales transactions were made totaling 148037 shares traded.
23 analysts projected Price Targets for CVS Health Corporation. The analysts believe that the company stock price could grow as high as $96. The Low Price target projection by analysts is $66.9 and the Mean Price Target is $86.52.
CVS Health Corporation (CVS) has the market capitalization of $80.91 Billion. The company rocked its 52-Week High of $106.67 on May 9, 2016 and touched its 52-Week Low of $69.3 on Nov 8, 2016.
The stock has Return on Assets (ROA) of 5.7 percent. Return on Equity (ROE) stands at 14.7% and Return on Investment (ROI) of 9.9 percent.
The stock is currently showing YTD performance of 0.57 Percent. The company has Beta Value of 0.84 and ATR value of 1.05. The Weekly and Monthly Volatility stands at 1.30% and 1.21%.